BioDelivery Sciences International, Inc.
BDSI
BDSI was delisted on the 22nd of March, 2022.
83 hedge funds and large institutions have $112M invested in BioDelivery Sciences International, Inc. in 2018 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 27 increasing their positions, 15 reducing their positions, and 7 closing their positions.
1,879% more call options, than puts
Call options by funds: $277K | Put options by funds: $14K
214% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 7
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
80% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 15
40% more capital invested
Capital invested by funds: $79.9M → $112M (+$31.6M)
22% more funds holding
Funds holding: 68 → 83 (+15)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$8.9M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$7.93M |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$4.68M |
| 4 |
FCMI
Foresite Capital Management II
Larkspur,
California
|
+$2.58M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.53M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
-$4.82M |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$740K |
| 3 |
BBA
Baker Bros. Advisors
New York
|
-$620K |
| 4 |
HP
Hikari Power
Tokyo,
Japan
|
-$257K |
| 5 |
Renaissance Technologies
New York
|
-$192K |
BDSI Hedge Fund Activity: Q3 2018 in Review
83 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q3 2018, worth a combined $112M — up 40% from $79.9M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new BDSI positions and 7 closed out — a net gain of 15 holders — while 27 added to existing stakes and 15 trimmed.
The largest buyer was Armistice Capital, adding an estimated $8.9M. The largest seller was Royce & Associates, cutting an estimated $4.82M.
- 83 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q3 2018, up from 68 in Q2 2018.
- Funds reported $112M of BioDelivery Sciences International, Inc. stock for Q3 2018, up 40% quarter-over-quarter.
- 22 funds opened new BioDelivery Sciences International, Inc. positions in Q3 2018 and 7 closed out, a net change of +15 holders.
- The largest BioDelivery Sciences International, Inc. buyer in Q3 2018 was Armistice Capital, an estimated $8.9M added.
- The largest BioDelivery Sciences International, Inc. seller in Q3 2018 was Royce & Associates, an estimated $4.82M sold.
Based on aggregated 13F filings for Q3 2018.